-
Octyl-α-Ketoglutarate and HIF-1α Metabolism
2026-08-18
A translational framework for using Octyl-α-ketoglutarate as a cell-permeable prolyl hydroxylase substrate to investigate HIF-1α regulation, TCA cycle dysfunction research, and IDH-linked metabolic vulnerabilities.
-
GSH-Responsive MOF Nanoparticles for Melanoma Therapy
2026-08-18
Hao et al. developed ICG-MOF-SS-AUNP12, a glutathione-responsive metal–organic framework nanoparticle that combines near-infrared photothermal therapy with PD-1/PD-L1 checkpoint inhibition. The study links stimulus-responsive peptide release, tumor-cell ablation, dendritic-cell maturation, and immune activation, while also highlighting the preclinical limitations that must be addressed before translation.
-
CH 223191: Mapping the AhR–Gut Repair Axis
2026-08-17
CH 223191 is more than a standard aryl hydrocarbon receptor antagonist: it can serve as a causal probe for separating protective microbiota–tryptophan–AhR signaling from toxicant-driven AhR activation. This thought-leadership guide connects recent ulcerative colitis findings with dioxin toxicology, outlines practical assay parameters, and defines the translational limits of pharmacological AhR blockade.
-
FDA-Approved Drug Screening for MERS-CoV Inhibition
2026-08-17
The reference study used a cell-based screen of FDA-approved compounds to identify four inhibitors of MERS-CoV replication, including Lopinavir (ABT-378), with activity extending to SARS-CoV and human coronavirus 229E. Its main practical contribution is a repurposing framework for rapidly prioritizing antiviral candidates while showing why cell-culture potency must be separated from mechanism, pharmacokinetics, and clinical efficacy.
-
Pheromones, Neurodevelopment, and C. elegans Degeneration
2026-08-16
Peng et al. show that pheromone exposure during the L1 stage can establish a developmental state that later accelerates neurodegeneration in adult C. elegans through convergent chemosensory and neuroendocrine signaling. The study links environmental perception to neuronal insulin-like signaling and autophagy inhibition, offering a mechanistic framework for investigating how early-life chemical cues influence proteostasis.
-
Cytochalasin D for Actin Uptake Assays
2026-08-15
Cytochalasin D provides a practical way to test whether actin remodeling contributes to nanoparticle uptake, epithelial morphology, proliferation, or infection-related phenotypes. This workflow connects a defined actin perturbation with human corneal epithelial cell models while emphasizing dose control, viability checks, and careful interpretation.
-
Kir4.1–Panx3 Signaling in Orofacial Neuropathic Pain
2026-08-14
Feng et al. identify a downstream link between loss of the satellite glial cell potassium channel Kir4.1 and pannexin 3 dysregulation in trigeminal ganglia during orofacial neuropathic pain. Their results connect Kir4.1 deficiency with reactive oxygen species and p38 MAPK activation, while genetic rescue and Panx3 inhibition provide complementary evidence for a glia-centered pain mechanism.
-
U0126 MEK1/2 Inhibitor: Applied Cell Workflows
2026-08-14
U0126 provides a practical, non-ATP-competitive route to suppress MEK1/2 and resolve ERK-dependent changes in inflammation, survival, proliferation, and organelle turnover. This guide translates recent microglial neuroinflammation findings into assay-ready workflows, controls, and troubleshooting strategies.
-
Ferritin Hybrid Vaccine for Influenza and SARS-CoV-2
2026-08-13
Song and colleagues developed an Escherichia coli-produced ferritin hybrid particle that co-displays influenza A M2e and SARS-CoV-2 spike tandem epitopes. The construct generated stronger antibody responses than antigen-only formats and showed dual functional activity, including SARS-CoV-2 pseudovirus inhibition, M2-expressing cell binding, and antibody-dependent cellular cytotoxicity.
-
AG-120 (Ivosidenib) Assay Workflows
2026-08-13
A scenario-based guide to using AG-120 (Ivosidenib), mutant IDH1 inhibitor, in 2-hydroxyglutarate, viability, proliferation, and differentiation assays. It explains solvent controls, time-course design, metabolic interpretation, and practical selection criteria for SKU B7805.
-
Transcription Termination Protects DNA After WEE1 Inhibition
2026-08-12
Landsverk and colleagues show that transcription termination limits replication-associated DNA damage after WEE1 inhibition with adavosertib. Genetic and pharmacological experiments identify read-through transcription as a modifiable source of transcription–replication conflicts and support CPSF73 inhibition as a potential combination strategy in prostate cancer models.
-
Wnt-C59: Selective PORCN Inhibitor Guide
2026-08-12
Wnt-C59 is a potent PORCN inhibitor that blocks Wnt ligand secretion and downstream Wnt/β-catenin signaling. Product and preclinical evidence supports its use in mechanistic studies of Wnt-driven cancer biology, including cholangiocarcinoma and WNT1-dependent tumor models.
-
Angiotensin I/II (1-5): RAS Workflow Guide
2026-08-11
Angiotensin I/II (1-5) provides a defined Asp-Arg-Val-Tyr-Ile peptide input for renin-angiotensin system research, including cardiovascular, renal, hypertension, and aldosterone-related assays. It should be used as a controlled peptide reagent rather than as a substitute for intact angiotensin I, angiotensin II, endogenous enzyme processing, or unrelated signaling tools.
-
Caspase-3 Colorimetric Assay Kit: Practical Guide
2026-08-11
The Caspase-3 Colorimetric Assay Kit (SKU K2008) provides a plate-reader or spectrophotometer readout for DEVD-dependent caspase-3 activity in biological samples. It is appropriate for apoptosis-related activity comparisons, but it should not be used alone to prove pathway causality, define upstream caspase activation, or replace orthogonal cell-death measurements.
-
Intravitreal Metformin in AMD Models: Study Insights
2026-08-10
This preclinical study examines intravitreal metformin as a locally delivered strategy that may address both choroidal neovascularization and retinal degeneration, two interconnected features of advanced age-related macular degeneration. Using explant and mouse injury models, the authors identify dose-dependent suppression of vessel growth, reduced IBA1-positive immune-cell infiltration, retinal protection, and downregulation of angiogenesis- and inflammation-associated genes.